by Wang therefore rapidly gained popularity. 3 Although the sensitivity of this technique was initially reported by Wang as 76%,4 we and others found the needle difficult to lodge into the mediastinum and this is reflected in subsequent reports of variable sensitivity in the diagnosis of lung and mediastinal malignancy.7`10 Since the early descriptions of the use of a flexible needle Wang has devised both an 18 gauge and 19 gauge needle. Overall, sensitivity using the Wang 18 gauge needle increased to 80% and with the 19 gauge needle to 89%."l' Both needles provide histological material for diagnosis. It is noteworthy that in these latter two studies CT staging was employed and so the improved sensitivity may in part have been due to better selection of the sample sites.
The presence of a cytopathologist in theatre has had a major impact on the sensitivity of ITNA in our institution with an improvement from 18-8% in an earlier study6 to 81%. The mean number of aspirates per procedure has increased but without complication. This study has shown that the sensitivity of TINA has increased still further when a preoperative CT scan is available to guide the operator to the best site for sampling. TTNA using the flexible needle is safe with only a few reports of complications and rare false positive aspirates."2-14
We have experienced no major complications with the rigid needle in this institution.
We thank the physicians and bronchoscopy staff who allowed us to use their patient records and Miss M McKinlay for typing the manuscript. Angiotensin converting enzyme (ACE) inhibitors are known to cause coughing in 5-10% of patients,' but the precise mechanism is still unclear. In the airways ACE degrades bradykinin and tachykinins such as substance p.23 Substance P has been reported to have a variety of effects on the airway including inducing cough,24 so it is possible that ACE inhibitorinduced coughing is due to decreased metabolism of substance P. To test this hypothesis we have measured the concentration of substance P in induced sputum after inhalation of hypertonic saline in patients with and without ACE inhibitor-induced cough.
Methods
The subjects were chosen from patients who had taken the ACE inhibitor enalapril (2-5 or 5 0 mg/day). Written informed consent for the protocol, which was reviewed and approved by the Tohoku University Committee on Clinical Investigation, was obtained from each patient. Patients were divided into two groups according to whether they coughed while taking enalapril or not. No subjects had respiratory disease and the respiratory function, measured as vital capacity (VC), forced expiratory volume in one second (FEV,), and arterial blood gas analysis, of all subjects was within normal limits. VC and FEV, were measured using a dry rolling seal spirometer (OST 80A, Chest Co, Tokyo, Japan) and arterial oxygen and carbon dioxide tensions (Pao2 and Paco2) and pH were determined with a pH/blood gas analyser (Model 1312; Instrumentation Laboratory Co, Lexington, Massachusetts, USA). Each subject had stopped taking enalapril at least one month before the sputum induction. In four of the cases with a cough enalapril was given again for 1-2 weeks and the concentration of substance P in the induced sputum was again measured.
Hypertonic saline (4%) inhalation was performed with an ultrasonic nebuliser5 for 15-30 minutes until a sputum volume of about 1 ml was collected. Because the samples contained saliva, we eliminated this contamination by visual inspection and inverted microscope examination. The sputum samples were immediately mixed with an inhibitor solution (2 x 10-5 M neutral endopeptidase inhibitor phosphoramidon, 2 x 10-5M kininase II inhibitor captopril, 500 kU/ml serine protease inhibitor aprotinin, and 1V2 mg/ml EDTA) to avoid degradation of substance P and stored at -70°C until assay.6
The sputum samples were diluted with acetic acid (4%, pH 4 0 adjusted by ammonium) to a final volume of 50 ml, homogenised using Polytron PT-10 (PT-35, Kinematica AG, Littau, Switzerland), and centrifuged at 40 000 g for 30 minutes. The obtained supernatant was loaded on reversed phase C18 cartridges (Sep-Pak C18, Millipore Co, Milford, Massachusetts, USA). After washing with 20ml 4% acetic acid (pH 4 0) and 20ml distilled water, substance P was eluted with 2 ml 80% acetonitrile in 0 1 % trifluoroacetic acid. Elutes were concentrated by spin vacuum evaporation, lyophilised, and dissolved with 0.15 ml assay buffer (50 nM phosphate buffer, pH 7 2, containing 3 7 g/ml EDTA and 0 5% bovine serum albumin). A total of 0-1 ml of the dissolved preparation was subjected to further radioimmunoassay for substance P. Radioimmunoassay for substance P was performed using "5I-labelled substance P (Amersham International, Amersham, UK) and antisubstance P rabbit serum (Amersham International). 0 1 ml samples were mixed with 0 5 ml assay buffer, 0-1 ml antiserum, and 0.1 ml 125I-substance P and stored at 4°C for 24 hours. A total of 0-2 ml dextran/charcoal suspension (0-2% dextran and 2% activated charcoal in assay buffer) was added to the reaction mixture and centrifuged at 2000 g for 10 minutes. The radioactivity of the supernatant was measured by a gamma counter (Model 5420, Packard Instrument Co, Meriden, Connecticut, USA). The concentration of substance P was calculated in terms of ml ofinduced sputum. In this system the sensitivity of immunoassayable substance P in saline was 1-60 fmol/ml. Furthermore, to determine how much substance P in the sputum was measurable we added substance P (30 fmol) to the sputum and measured the immunoreactivity of the peptide. In such cases 99 3 (4 3)% of immunoassayable substance P was detected.6 DATA ANALYSIS Data are expressed as mean (SE). Comparisons of the concentrations of substance P in induced sputum between the two groups were made with the Mann-Whitney U test (two tailed). A p value of <0 05 was considered significant.
Results
The cough positive group consisted of nine subjects (three men) of mean age 60-6 years (range 46-74), of whom one was a smoker and two were ex-smokers. The cough negative group consisted of five subjects (two men) of mean age 53-2 years (range 37-72), three of whom were smokers.
Inhalation of hypertonic saline caused sputum production (approximately 1 ml) in each case. There was no significant difference in the mean volume of sputum induced in the two groups (0 9 (0 3) ml for the cough positive group and 0 8 (0 1) ml for the cough negative group). The percentage of squamous cells in the sputum was less than 10% in all subjects, indicating that the sample of sputum was primarily from the tracheobronchial tree. free from airway diseases. The percentage ofthe subgroup seems low, because ACE inhibitors cause coughing in only 5-10% of patients takof substance P in the ing them. The recent report in which we own in the figure. In the showed a low concentration of substance P in the substance P con-the airways of subjects free from airways disiificantly higher (16-6 ease6 had only nine normal subjects so we might those of the cough have missed the existence of such a subgroup. 0 5) fmol/ml) (p<001).
In conclusion, the mechanisms of ACE in-.e cough positive group hibitor-induced coughing may involve subat dose of enalapril de-stance P-mediated airway priming, but the final but the concentrations triggering of ACE inhibitor-induced coughing induced sputum while is unlikely to be due to this peptide. Other (3 2) fmol/ml) were not peptides such as bradykinin which are also rom the values while off degraded by ACE may be important in trignol/ml). gering coughing. Newly developed substance P receptor antagonists8 used for patients with coughing induced by ACE inhibitors may be useful for confirming this hypothesis. In this study we have shown that the concentration of substance P in sputum induced by hypertonic saline is significantly higher in patients with ACE inhibitor-induced coughing than in those without coughing one month after stopping enalapril. In the airways substance P is localised in sensory C fibres.2 Hypertonic saline inhalation challenge releases tachykinin from airway sensory nerves.7 The increased concentration of substance P in the induced sputum of the cough positive group may therefore be explained by the increased release of substance P from sensory nerves or decreased breakdown of substance P in the airways. Substance P has various actions on the airways including coughing and, in guinea pigs, even a low concentration of substance P can cause coughing.4 Taken together, substance P may be involved in the pathogenesis of ACE inhibitorinduced coughing.
Because ACE inhibitors were stopped one month before the measurement of substance P
